Swedish gut analysis and microbiome therapeutics player Carbiotix will partner with the University of Verona on neuroinflammation research using its Microbiome Modular Therapeutics (MMT) platform.
Clinical trials involving diet are severely under-funded and more difficult to complete than drugs studies, say researchers who warn that nutrition studies are prone to bias, are often too small and of too short duration and regularly change outcome...
A world-class line up of international experts in the microbiome, probiotics and prebiotics will take centre stage in Dublin this February as Probiota 2020 bridges the science and industry divide.
People with depression or vulnerability to depression should be encouraged to eat plant-based diets with higher levels of grains, fibres and fish, according to new recommendations published by the MyNetGut consortium.
New clinical trial data suggests supplementation with vitamin D3 could help improve depression scores in older adults with moderate to severe depression.
Calling all probiotic, prebiotic and microbiome focused start-ups and researchers: Apply now!
Are you an innovative start-up, or a researcher with compelling new data? Would you like to present your company or latest scientific findings at the leading microbiome-focused event? If so, we would like to hear from you!
After its sell-out 2019 edition in Copenhagen, Probiota will be heading to Dublin in February 2020. Check out the key themes and outline agenda for the leading probiotic, prebiotic and microbiome event … and register now for the three-day festival of...
An expert panel has identified that interventions based on biomarkers and disease prevention need to be the key priority areas for the nutritional scientific community to promote healthy ageing as the number of seniors in APAC soars.
Live biotherapeutics firm 4D pharma is to commence human trials looking into how effective a microbiota-derived bacterial strain is in managing severe asthma.
Ferring Pharmaceuticals, the Eliava Foundation and Intralytix are to form a research collaboration that focuses on developing bacteriophage-based products, which target the vaginal microbiome.
Bacteriophages can have a cascade of effects on the microbiome and change metabolite levels, with implications for therapeutic use, new research suggests.
Global omega-3 player KD Pharma says the new site at Seal Sands will expand its capacity for manufacturing omega-3-based intermediates, especially for those use in producing active pharmaceutical ingredients (APIs).
With ever-blurring lines between the food and pharmaceutical space, the NutraIngredients team asked experts at our recent Probiota conference how they believe the microbiome space will develop in the future.
Swedish-based Carbiotix continues to build on its gut health testing activities, having closed its latest funding round, bringing the total raised to date at €1m over the past 4 years.
